# US 6,727,348 B2 · Compositions and methods for the diagnosis and treatment of body weight disorders, including obesity

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,727,348 B2
- Document ID: US6727348B2
- Status: Granted
- Kind: B2
- Application number: 09/893,238
- Filed: 2001-06-27
- Published: 2002-10-17
- Granted: 2004-04-27
- Earliest claimed: 1998-07-21
- Assignees: Millennium Pharmaceuticals, Inc.
- Inventors: Karen Moore; Deborah Lynn Nagle
- Web page: https://patentgrep.com/patent/US6727348B2

## CPC

- C07K 14/47: from mammals
- C07K 2319/00: Fusion polypeptide
- C07K 2319/02: containing a signal sequence
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

The present invention relates to mammalian mahogany genes, including the human mahogany gene, which are novel genes involved in the control of mammalian body weight. The invention encompasses nucleotide sequences of the mahogany gene, host cell expression systems of the mahogany gene, and hosts which have been transformed by these expression systems, including transgenic animals. The invention also encompasses novel mahogany gene products, including mahogany proteins, polypeptides and peptides containing amino acid sequences mahogany proteins, fusion proteins of mahogany proteins polypeptides and peptides, and antibodies directed against such mahogany gene products. The present invention also relates to methods and compositions for the diagnosis and treatment of mammalian body weight disorders, including obesity, cachexia, and anorexia, and for the identification of subjects susceptible to such disorders. Further, the invention relates to methods of using the mahogany gene and gene products of the invention for the identification of compounds which modulate the expression of the mahogany gene and/or the activity of the mahogany gene product. Such compounds can be useful as therapeutic agents in the treatment of mammalian body weight disorders, including obesity, cachexia, and anorexia.

## Claims

### Claim 1

An isolated polypeptide comprising the amino acid sequence of SEQ ID NO: 2, SEQ ID NO: 9, SEQ ID NO: 11, SEQ ID NO: 13, SEQ ID NO: 15, SEQ ID NO: 17, or SEQ ID NO: 19.

### Claim 2 (depends on 1)

The isolated polypeptide of claim 1, wherein the polypeptide comprises the amino acid sequence of SEQ ID NO: 2.

### Claim 3 (depends on 1)

The isolated polypeptide of claim 1 wherein the polypeptide comprises the amino acid sequence of SEQ ID NO: 9.

### Claim 4 (depends on 1)

The isolated polypeptide of claim 1, wherein the polypeptide comprises the amino acid sequence of SEQ ID NO: 11.

### Claim 5 (depends on 1)

The isolated polypeptide of claim 1, wherein the polypeptide comprises the amino acid sequence of SEQ ID NO: 13.

### Claim 6 (depends on 1)

The isolated polypeptide of claim 1, wherein the polypeptide comprises the amino acid sequence of SEQ ID NO: 15.

### Claim 7 (depends on 1)

The isolated polypeptide of claim 1, wherein the polypeptide comprises the amino acid sequence of SEQ ID NO: 17.

### Claim 8 (depends on 1)

The isolated polypeptide of claim 1, wherein the polypeptide comprises the amino acid sequence of SEQ ID NO: 19.

### Claim 9

An isolated polypeptide encoded by the open reading frame of SEQ ID NO:1, SEQ ID NO: 8; SEQ ID NO: 10; SEQ ID NO: 12; SEQ ID NO: 14; SEQ ID NO: 16; or SEQ ID NO: 18.

### Claim 10 (depends on 9)

The isolated polypeptide of claim 9, wherein the polypeptide is encoded by a nucleic acid molecule which hybridizes under said stringent hybridization and wash conditions to a complement of the open reading frame of SEQ ID NO: 14.

### Claim 11 (depends on 9)

The isolated polypeptide of claim 9, wherein the polypeptide is encoded by a nucleic acid molecule which hybridizes under said stringent hybridization and wash conditions to a complement of the open reading frame of SEQ ID NO: 16.

### Claim 12 (depends on 9)

The isolated polypeptide of claim 9, wherein the polypeptide is encoded by a nucleic acid molecule which hybridizes under said stringent hybridization and wash conditions to a complement of the open reading frame of SEQ ID NO: 18.

### Claim 13

An isolated polypeptide encoded by a nucleic acid molecule which hybridizes under stringent conditions to a complement of the open reading frame of SEQ ID NO:1, SEQ ID NO: 8; SEQ ID NO: 10; SEQ ID NO: 12; SEQ ID NO: 14; SEQ ID NO: 16; or SEQ ID NO: 18, wherein said hybridization occurs across the full length of said nucleic acid molecule and across the full length of said complement, wherein said stringent hybridization conditions comprise hybridizing in 0.5 M NaHPO4, 7% SDS, 1 mM EDTA at 68° C. and washing in 0.1%×SSC/0/1% at 68° C., and wherein said polypeptide modulates the melanocortin signal transduction pathway.

### Claim 14 (depends on 13)

The isolated polypeptide of claim 13, wherein the polypeptide is encoded by a nucleic acid molecule which hybridizes under said stringent hybridization and wash conditions to a complement of the open reading frame of SEQ ID NO: 14.

### Claim 15 (depends on 13)

The isolated polypeptide of claim 13, wherein the polypeptide is encoded by a nucleic acid molecule which hybridizes under said stringent hybridization and wash conditions to a complement of the open reading frame of SEQ ID NO: 16.

### Claim 16 (depends on 13)

The isolated polypeptide of claim 13, wherein the polypeptide is encoded by a nucleic acid molecule which hybridizes under said stringent hybridization and wash conditions to a complement of the open reading frame of SEQ ID NO: 18.

### Claim 17

A fusion polypeptide comprising the amino acid sequence of SEQ ID NO: 2, SEQ ID NO: 9, SEQ ID NO: 11, SEQ ID NO: 13, SEQ ID NO: 15, SEQ ID NO: 17, or SEQ ID NO: 19 and a heterologous amino acid sequence.
